| 1 |
35558742 | Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China. | 2022 |
1 |
| 2 |
34542866 | Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study. | 2021 Nov |
1 |
| 3 |
31907828 | Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass. | 2020 Mar |
1 |
| 4 |
32404599 | Effect of blood insulin level on postprandial hypotension in elderly people. | 2020 Aug |
2 |
| 5 |
29524187 | Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial. | 2018 Apr |
1 |
| 6 |
28917933 | The complete genome sequence of the actinobacterium Streptomyces glaucescens GLA.O (DSM 40922) carrying gene clusters for the biosynthesis of tetracenomycin C, 5`-hydroxy streptomycin, and acarbose. | 2017 Nov 20 |
1 |
| 7 |
27052634 | Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity. | 2016 Aug |
1 |
| 8 |
27699014 | Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study. | 2016 Oct |
4 |
| 9 |
28017142 | Gliclazide-Induced Insulin Autoimmune Syndrome: A Rare Case Report and Review on Literature. | 2016 |
1 |
| 10 |
26055217 | Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study. | 2015 Jun |
1 |
| 11 |
26640487 | Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study. | 2015 |
1 |
| 12 |
24808918 | Comparison of the Effects of Acarbose and TZQ-F, a New Kind of Traditional Chinese Medicine to Treat Diabetes, Chinese Healthy Volunteers. | 2014 |
3 |
| 13 |
23530576 | A prospective, randomized, open-label study comparing the efficacy and safety of preprandial and prandial insulin in combination with acarbose in elderly, insulin-requiring patients with type 2 diabetes mellitus. | 2013 Jun |
2 |
| 14 |
23923633 | Determination of acarbose by capillary zone electrophoresis. | 2013 Jul |
2 |
| 15 |
22136721 | Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion. | 2012 Mar |
1 |
| 16 |
22967344 | [Improvement in blood glucose fluctuations of insulin-treated type 1 diabetic patients with additional use of acarbose and assessed by continuous blood glucose monitoring program]. | 2012 Aug |
1 |
| 17 |
21118681 | Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load. | 2011 Jan 25 |
2 |
| 18 |
21367625 | RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. | 2011 Jul-Aug |
3 |
| 19 |
21488802 | Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation. | 2011 Jun |
6 |
| 20 |
20385430 | Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? | 2010 Jun |
1 |
| 21 |
20831680 | Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin. | 2010 Oct |
1 |
| 22 |
19689250 | Effects of acarbose on proinsulin and insulin secretion and their potential significance for the intermediary metabolism and cardiovascular system. | 2009 Aug |
4 |
| 23 |
18377903 | Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome. | 2008 Oct |
1 |
| 24 |
17515447 | Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. | 2007 Jul |
2 |
| 25 |
17924867 | Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy. | 2007 Nov |
3 |
| 26 |
18062354 | [Therapeutic options for metabolic syndrome in obese patients]. | 2007 Sep-Oct |
1 |
| 27 |
16784967 | Acarbose improves fibrinolytic activity in patients with impaired glucose tolerance. | 2006 Jul |
1 |
| 28 |
16801564 | Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes. | 2006 Jul |
1 |
| 29 |
15787675 | alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. | 2005 Apr |
2 |
| 30 |
15846673 | Alpha-glucosidase inhibitors for type 2 diabetes mellitus. | 2005 Apr 18 |
1 |
| 31 |
15893133 | Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome. | 2005 |
2 |
| 32 |
15922116 | Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH). | 2005 |
2 |
| 33 |
14686965 | The effect of acarbose on insulin resistance in obese hypertensive subjects with normal glucose tolerance: a randomized controlled study. | 2004 Jan |
2 |
| 34 |
15199620 | [Clinical observation on improving senile postprandial hyperglycemia and insulin sensitivity with combination of acarbose and liuwei nengxiao capsule]. | 2004 May |
2 |
| 35 |
15216448 | The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes. | 2004 Jun |
3 |
| 36 |
15287932 | Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. | 2004 Sep |
1 |
| 37 |
15334790 | Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application. | 2004 Jun |
2 |
| 38 |
16462710 | Effects of acarbose in beta-thalassaemia major patients with normal glucose tolerance and hyperinsulinism. | 2004 Dec |
2 |
| 39 |
12482640 | Acarbose in the treatment of elderly patients with type 2 diabetes. | 2003 Jan |
2 |
| 40 |
12542723 | Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients. | 2003 Jan |
2 |
| 41 |
12699398 | Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? | 2003 |
2 |
| 42 |
12706319 | Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study. | 2003 May |
3 |
| 43 |
12790691 | Current management strategies for coexisting diabetes mellitus and obesity. | 2003 |
1 |
| 44 |
12965108 | Efficacy of acarbose in Chinese subjects with impaired glucose tolerance. | 2003 Sep |
1 |
| 45 |
14703948 | Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes. | 2003 Oct |
2 |
| 46 |
17535077 | Effect of add-on acarbose to insulin therapy in routine clinical practice. | 2003 |
1 |
| 47 |
11796175 | Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients. | 2002 Feb |
2 |
| 48 |
11850098 | Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes. | 2002 Mar |
9 |
| 49 |
11872380 | The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents. | 2002 Jan-Feb |
2 |
| 50 |
11874186 | Impaired glucose homeostasis in young adult thalassemic patients: a pilot study with acarbose. | 2002 Feb |
1 |